Article Text

other Versions

PDF
D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma, and phaeochromocytoma.
  1. Lisa Browning (lisabrowning{at}doctors.org.uk)
  1. Department of Histopathology, Wycombe Hospital, High Wycombe, United Kingdom
    1. Andrew Parker (andrew.parker{at}orh.nhs.uk)
    1. Department of Cellular Pathology, John Radcliffe Hospital, Oxford, United Kingdom
      1. David Bailey (david.bailey5{at}virgin.net)
      1. Department of Histopathology, Wycombe Hospital, High Wycombe, United Kingdom

        Abstract

        Background: The morphological similarities between the cells of clear cell renal cell carcinoma (CCRCC) and those of the adrenal cortex impose diagnostic difficulties, for example in the context of a solitary nodule in the adrenal gland in a patient with renal cell carcinoma (RCC). This problem is confounded by the variable and patchy staining seen with the established panel of antibodies utilised in this context, namely EMA, cytokeratins, vimentin, inhibin, melan-A, and RCC marker; particularly on biopsy material. We observed that D2-40, an antibody commonly used to highlight lymphatic endothelial cells, is consistently positive in the normal adrenal cortex. We subsequently investigated its utility in distinguishing adrenal cortical cells from those of CCRCC, and from phaeochromocytoma.

        Aims: To investigate the utility of D2-40 in distinguishing neoplastic and non-neoplastic adrenal cortical cells from those of CCRCC, and from phaeochromocytoma

        Method: D2-40 antibody was applied to tissue sections from 10 normal adrenal glands, 15 renal carcinomas (13 clear cell, 2 papillary variants), 1 metastatic CCRCC in the adrenal gland,6 adrenal cortical hyperplasias, 5 adrenal cortical adenomas, 3 adrenal cortical carcinomas, and 4 phaeochromocytomas.

        Results: D2-40 was strongly and diffusely positive in the cells of the neoplastic and non-neoplastic adrenal cortex, but negative in the cells of the CCRCC, both primary and metastatic, in 100% of the cases. The cells of the adrenal medulla, and those of the phaeochromocytomas, were negative for D2-40.

        • D2-40
        • adrenal cortex
        • adrenal gland
        • renal carcinoma

        Statistics from Altmetric.com

        Request permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.